These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 35016680)

  • 1. Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension.
    Guo M; Zhang M; Cao X; Fang X; Li K; Qin L; He Y; Zhao J; Xu Y; Liu X; Li X
    Respir Res; 2022 Jan; 23(1):6. PubMed ID: 35016680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRB3 mediates vascular remodeling by activating the MAPK signaling pathway in hypoxic pulmonary hypertension.
    Cao X; Fang X; Guo M; Li X; He Y; Xie M; Xu Y; Liu X
    Respir Res; 2021 Dec; 22(1):312. PubMed ID: 34906150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1.
    Zhao TF; Wang SY; Zou XZ; Zhao HD
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3495-3502. PubMed ID: 31081105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of activated κ-opioid receptor (κ-OR) on the role of calcium sensing receptor (CaSR) in preventing hypoxic pulmonary hypertension development.
    Li J; Jia M; Liu M; Cao Z; Wang X; Feng N; Gu X; Zhang S; Fan R; Guo H; Wang Y; Liu M; Pei J
    Biomed Pharmacother; 2020 May; 125():109931. PubMed ID: 32066040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes derived from mesenchymal stromal cells exert a therapeutic effect on hypoxia-induced pulmonary hypertension by modulating the YAP1/SPP1 signaling pathway.
    Chen YX; Deng ZH; Xue-Gao ; Qiang-Du ; Juan-Yin ; Chen GH; Li JG; Zhao YM; Zhang HT; Zhang GX; Qian JX
    Biomed Pharmacother; 2023 Dec; 168():115816. PubMed ID: 37918254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis reveals that Xbp1s promotes hypoxic pulmonary hypertension through the p-JNK MAPK pathway.
    Jiang H; Niu Y; He Y; Li X; Xu Y; Liu X
    J Cell Physiol; 2022 Mar; 237(3):1948-1963. PubMed ID: 34964131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alveolar epithelial cells are involved in pulmonary vascular remodeling and constriction of hypoxic pulmonary hypertension.
    Wang Y; Li X; Niu W; Chen J; Zhang B; Zhang X; Wang Y; Dang S; Li Z
    Respir Res; 2021 May; 22(1):134. PubMed ID: 33947399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.
    Xia S; Tai X; Wang Y; An X; Qian G; Dong J; Wang X; Sha B; Wang D; Murthi P; Kalionis B; Wang X; Bai C
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension.
    Liu Y; Nie X; Zhu J; Wang T; Li Y; Wang Q; Sun Z
    J Cell Mol Med; 2021 Jan; 25(2):1221-1237. PubMed ID: 33340241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nur77 induced by HIF-1α mediates vascular remodeling in hypoxic pulmonary hypertension.
    Mao C; Huang J; Liu H; Liu Y; Hu Z; Xu R
    Cell Mol Biol (Noisy-le-grand); 2024 Jun; 70(6):233-237. PubMed ID: 38836656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reoxygenation Reverses Hypoxic Pulmonary Arterial Remodeling by Inducing Smooth Muscle Cell Apoptosis via Reactive Oxygen Species-Mediated Mitochondrial Dysfunction.
    Chen J; Wang YX; Dong MQ; Zhang B; Luo Y; Niu W; Li ZC
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
    Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
    Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell-derived exosomes ameliorate hypoxic pulmonary hypertension by inhibiting the Hsp90aa1/ERK/pERK pathway.
    Deng ZH; Chen YX; Xue-Gao ; Yang JY; Wei XY; Zhang GX; Qian JX
    Biochem Pharmacol; 2024 Aug; 226():116382. PubMed ID: 38909785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of m6A demethylase ALKBH5 alleviates hypoxia-induced pulmonary arterial hypertension via inhibiting Cyp1a1 mRNA decay.
    Gu N; Shen Y; He Y; Li C; Xiong W; Hu Y; Qiu Z; Peng F; Han W; Li C; Long X; Zhao R; Zhao Y; Shi B
    J Mol Cell Cardiol; 2024 Sep; 194():16-31. PubMed ID: 38821243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy.
    Ferguson BS; Wennersten SA; Demos-Davies KM; Rubino M; Robinson EL; Cavasin MA; Stratton MS; Kidger AM; Hu T; Keyse SM; McKnight RA; Lane RH; Nozik ES; Weiser-Evans MCM; McKinsey TA
    Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H382-H389. PubMed ID: 34142888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tibetan mesenchymal stem cell-derived exosomes alleviate pulmonary vascular remodeling in hypoxic pulmonary hypertension rats.
    Zhang Q; Liu H; Liu C; Wang Y; Huang P; Wang X; Ma Y; Ma L; Ge R
    Stem Cells; 2024 Aug; 42(8):720-735. PubMed ID: 38717187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCγ1 axis.
    Xu J; Zhong Y; Yin H; Linneman J; Luo Y; Xia S; Xia Q; Yang L; Huang X; Kang K; Wang J; Niu Y; Li L; Gou D
    J Hypertens; 2022 Sep; 40(9):1795-1807. PubMed ID: 35848503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertension.
    Zhou JJ; Li H; Li L; Li Y; Wang PH; Meng XM; He JG
    J Cell Physiol; 2021 Sep; 236(9):6297-6311. PubMed ID: 33507567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Ca
    Guo S; Shen Y; He G; Wang T; Xu D; Wen F
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28679649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.